LifeSci Communications Fierce Pharma Asia—Takeda's Anima mRNA translation pact, China digital health incubator; Daiichi's COVID-19 vaccine
Por um escritor misterioso
Descrição
Takeda penned a potentially billion-dollar deal with Anima Biotech to work on mRNA translation modulators for neurological diseases. The Japanese pharma als
Purified Rat Anti-Human IL-10
COVID-19 tracker: Pfizer, Moderna vaccines sharply cut hospitalizations in older adults, CDC data show
Anima Biotech - mRNA Lightning Platform
Takeda bags mRNA translation modulators in $120M Anima deal
Anima Biotech - mRNA Lightning Platform
Collection of Healthcare News and Biomedical Development — Mar. and April 2021, by Willies Wu
Applied Sciences August-1 2020 - Browse Articles
BioSpectrum Asia Jan 2023 - Flip eBook Pages 1-50
LifeSci Communications Fierce Pharma Asia—Takeda's Anima mRNA translation pact, China digital health incubator; Daiichi's COVID-19 vaccine
Anima Biotech - mRNA Lightning Platform
de
por adulto (o preço varia de acordo com o tamanho do grupo)
